(Press-News.org) A new study evaluated the effect of hybrid-closed loop Control-IQ technology in the pooled data from three randomized controlled trials, comparing Control-IQ to a control group using continuous glucose monitoring in people with type 1 diabetes. The study, which examined subgroup based on baseline characteristics such as race/ethnicity, socio-economic status, pre-study insulin delivery modality, and baseline glycemic control, is published in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT). Click here to read the article now.
Roy W. Beck, MD, PhD, from the JAEB Center for Health Research, and coauthors, reported that time in range (70-180 mg/dL) in the Control-IQ group increased from 57%±17% at baseline to 70%±11% during follow up. In the control group the time in range was 56%±15% and 57%±14%, respectively. This represents an increase of 2.8 hours per day on average.
“Significant reductions in mean glucose, hyperglycemia metrics, hypoglycemic metrics and HbA1c also were observed,” stated the investigators. “The greatest benefit was observed in participants with the worst baseline glycemic control in whom the auto-bolus feature of the Control-IQ algorithm appears to have substantial impact,” they concluded.
Editor-in-Chief of Diabetes Technology & Therapeutics Satish Garg, MD, from the University of Colorado Denver, Barbara Davis Center for Childhood Diabetes, states, “Increasing improvements in diabetes technologies has improved glucose control as measured by Time-in-Range with a significant reduction in hypoglycemia as shown above.”
About the Journal
Diabetes Technology & Therapeutics (DTT) is a monthly peer-reviewed journal that covers new technology and new products for the treatment, monitoring, diagnosis, and prevention of diabetes and its complications. Led by Editor-in-Chief Satish Garg, MD, University of Colorado Denver, Barbara Davis Center for Childhood Diabetes, the Journal covers breakthrough technologies and new therapeutic drug classes, behavioral aspects and approaches to diabetes care, and the latest advancements and applications of new and emerging technologies including continuous glucose monitoring, alternate insulin delivery methods, artificial pancreas, telemedicine and computerized case management, new insulins with ultra-rapid onset of action, and detection and prevention of hypoglycemia. Tables of contents and a free sample issue may be viewed on the Diabetes Technology & Therapeutics (DTT) website. DTT is the official journal of the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD).
About the Publisher
Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, and public health and policy. For complete information, please visit the Mary Ann Liebert, Inc. website.
END
A meta-analysis of hybrid-closed loop control-IQ technology
2023-04-17
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Leaps in artificial blood research aim to improve product safety, efficacy
2023-04-17
COLUMBUS, Ohio – Researchers have made huge strides in ensuring that red blood cell substitutes – or artificial blood – are able to work safely and effectively when transfused into the bloodstream.
The key is to make the artificial blood molecules big enough so they don’t leak from blood vessels into tissue and cause dangerous cardiovascular side effects, notes a new study led by researchers from The Ohio State University.
Although blood loss is typically treated by transfusing units of donated blood, in cases where transfusions aren’t readily ...
Ye receives funding for collaborative research: Ri: Small: Motion Field Understanding for Enhanced Long-Range Imaging
2023-04-17
Jinwei Ye, Assistant Professor, Computer Science, received funding from the National Science Foundation for the project: "Collaborative Research: RI: Small: Motion Field Understanding for Enhanced Long-Range Imaging."
Ye is collaborating with Nianyi Li, Assistant Professor of Computer Science at Clemson University, and Suren Jayasuriya, Assistant Professor, Arts Media and Engineering, and Assistant Professor, School of Electrical, Energy and Computer Engineering, at Arizona State University.
As ...
VA, NIH launch study of Gulf War Illness
2023-04-17
The Department of Veterans Affairs (VA) and National Institutes of Health have launched a study to gain a better understanding of the chronic symptoms of Gulf War Illness. The disease affects multiple systems in the body and includes chronic symptoms such as fatigue, headache, memory and cognitive difficulties, joint and muscle pain, poor sleep, and problems with gastrointestinal and respiratory function. It affects about a third of the nearly 700,000 men and women who served in the Persian Gulf during operations Desert Shield and Desert Storm.
“This is an important collaboration that we hope will lead to many answers to those ...
The 411 on marijuana use and cardiovascular health ahead of 4/20 Day
2023-04-17
DALLAS, April 17, 2023 — Legalization of marijuana, for both medical and recreational use, is on the rise across the U.S. The American Heart Association, the world’s leading nonprofit organization focused on heart and brain health for all, warns that using marijuana may increase your risk of deadly cardiovascular diseases, heart attacks and strokes, according to research evidence noted in two scientific statements published by the Association.
The Association’s 2020 scientific statement Medical Marijuana, Recreational Cannabis, and Cardiovascular Health, ...
Researchers discover a new embryonic brain circuit
2023-04-17
EMBARGOED UNTIL 17-APR-2023 11:00 ET
Basel, April 17, 2023 Using a new approach for studying live embryonic mouse brains at single-cell resolution, researchers have identified an active multi-layer circuit that forms in the cortex during an unexpectedly early stage of development. Perturbing the circuit genetically led to changes similar to those seen in the brains of people with autism. The findings are reported today in Cell by a team based at the Institute of Molecular and Clinical Ophthalmology Basel.
“Understanding the detailed development of cell types and circuits in the cortex can provide ...
Study links poor diet to 14 million cases of type 2 diabetes globally
2023-04-17
A research model of dietary intake in 184 countries, developed by researchers at the Friedman School of Nutrition Science and Policy at Tufts University, estimates that poor diet contributed to over 14.1 million cases of type 2 diabetes in 2018, representing over 70% of new diagnoses globally. The analysis, which looked at data from 1990 and 2018, provides valuable insight into which dietary factors are driving type 2 diabetes burden by world region. The study was published April 17 in the journal Nature Medicine.
Of the 11 dietary factors considered, three had an outsized contribution to the rising global incidence of type 2 diabetes: ...
SpyLigation uses light to switch on proteins
2023-04-17
Scientists can now use light to activate protein functions both inside and outside of living cells. The new method, called light-activated SpyLigation, can turn on proteins that are normally off to allow researchers to study and control them in more detail. This technology has potential uses in tissue engineering, regenerative medicine, and understanding how the body works.
Proteins perform nearly every important task in biology, including processing DNA, metabolizing nutrients, and fighting off infections. When, where, and how proteins become active is important for a variety of biological processes. Increasingly, ...
Dexamethasone for inpatients with COVID-19 in a national cohort
2023-04-17
About The Study: In this national multicenter cohort study of inpatients with COVID-19, early administration of dexamethasone was associated with significantly reduced odds of mortality or discharge to hospice in those requiring supplemental oxygen or mechanical ventilation and/or extracorporeal membrane oxygenation but not in those requiring no supplemental oxygen or noninvasive positive pressure ventilation. These results support the continued use of systemic dexamethasone in patients hospitalized with COVID-19.
Authors: Laine ...
Investigational drug may improve stem cell transplantation for multiple myeloma patients
2023-04-17
The standard treatment for patients with multiple myeloma often includes stem cell transplantation in which the patient’s own stem cells are harvested and stored while the patient receives intensive chemotherapy to kill the cancer. Then, the patient’s stem cells are returned to the patient to help with recovery. But for a significant proportion of patients, the number of stem cells that can be harvested is not optimal for transplant and negatively affects patient outcomes.
However, an international phase 3 clinical trial led by physicians at Washington University School of Medicine in St. Louis has shown that the investigational ...
University of Rochester researchers discover how to steer army of immune cells toward cancer
2023-04-17
Immunotherapy, particularly CAR T-Cell treatment for cancer, is extending the lives of many patients. But sometimes the therapy randomly migrates to places it shouldn’t go, tucking into the lungs or other noncancerous tissue and causing toxic side effects. A University of Rochester/Wilmot Cancer Institute team discovered the molecule responsible for guiding T cells toward tumors, setting the stage for scientists to improve upon the groundbreaking treatment.
The next step is to find a drug that can manipulate the ...